Reports of Radiotherapy and Oncology

Published by: Kowsar

Integrative Oncology: Hope or Hype?

Taiebeh Taheripanah 1 , Mahdi Sardari 2 and Hossein Rezaeizadeh 2 , *
Authors Information
1 Radiation Oncologist, Besat Hospital, AJA University of Medical Sciences, Tehran, IR Iran
2 Department of Traditional Medicine, Persian Medicine and Pharmacy Research Center, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Reports of Radiotherapy and Oncology: June 28, 2015, 2 (2); e3654
  • Published Online: June 12, 2015
  • Article Type: Review Article
  • Received: April 1, 2015
  • Accepted: May 29, 2015
  • DOI: 10.17795/rro-3654

To Cite: Taheripanah T, Sardari M, Rezaeizadeh H. Integrative Oncology: Hope or Hype?, Rep Radiother Oncol. 2015 ; 2(2):e3654. doi: 10.17795/rro-3654.

Abstract
Copyright © 2015, Iranian Society of Clinical Oncology.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
References
  • 1. Bell RM. A review of complementary and alternative medicine practices among cancer survivors. Clin J Oncol Nurs. 2010; 14(3): 365-70[DOI][PubMed]
  • 2. U.S. Department of Health and Human Services . 2009;
  • 3. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000; 18(13): 2505-14[PubMed]
  • 4. Gow CH, Chang YL, Hsu YC, Tsai MF, Wu CT, Yu CJ, et al. Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. Ann Oncol. 2009; 20(4): 696-702[DOI][PubMed]
  • 5. Räsänen C. Factors influencing the use of complementary and alternative medicine among cancer patients. 2010;
  • 6. Tascilar M, de Jong FA, Verweij J, Mathijssen RH. Complementary and alternative medicine during cancer treatment: beyond innocence. Oncologist. 2006; 11(7): 732-41[DOI][PubMed]
  • 7. Wyatt G, Sikorskii A, Wills CE, Su H. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res. 2010; 59(1): 58-66[DOI][PubMed]
  • 8. National Center for Complementary and Alternative Medicine. . Exploring the Science of Complementary and Alternative Medicine. 2011–2015;
  • 9. Ulbricht C, Cohen L, Lee R. DeVita, Hellman, Rosenberg's Cancer. Principles & Practice of Oncology. 2011;
  • 10. Cancer Treatment Centers of America. . How can genomic testing help patients now?.
  • 11. University of California SF. Osher Center For Integrative Medicine
  • 12. The Simms/Mann - UCLA Center for Integrative Oncology. .
  • 13. Block Center for Integrative Cancer Treatment. .
  • 14. Johns Hopkins Medicine. . GIM Program in Integrative Medicine
  • 15. Dana-Farber Cancer Institute. .
  • 16. Mayo Clinic Staff. . Complementary and Integrative Medicine
  • 17. Memorial Sloan Kettering Cancer Center. . Integrative Medicine
  • 18. University of Texas: MD Anderson Cancer Center. . Integrative Medicine Program
  • 19. University of Texas: MD Anderson Cancer Center. . Patient and Cancer Information.
  • 20. Society for Integrative Oncology. . Clinical Practice Guidelines
  • 21. Jacobsen PB, Davis K, Cella D. Assessing quality of life in research and clinical practice. Oncology (Williston Park). 2002; 16(9 Suppl 10): 133-9[PubMed]
  • 22. Beuth J, Moss RW, Abel U. Complementary oncology: adjunctive methods in the treatment of cancer. 2005;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments